Ranbaxy Can Develop Drugs At A Fifth Of Global Costs

Our Corporate Bureau BUSINESS STANDARD

Last Updated : Jan 28 2013 | 1:58 AM IST

Superior risk management, cost effectiveness will be the key

Ranbaxy Laboratories Ltd, India

Connect with us on WhatsApp

More From This Section

Sahara's significant other worth

'KFA lenders to recover Rs 1,000 cr by March'

Sebi pre-empting legal process: Sahara

IT sector takes to non-linear growth

First Published: Jun 04 2003 | 12:00 AM IST

Explore News

Next Story